Gall Stone Disease Clinical Trial
Official title:
Promising Initial Experience With Intra-operative Fluorescent Cholangiography
Verified date | May 2014 |
Source | Hvidovre University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Health and Medicines Authority |
Study type | Interventional |
Intraoperative fluorescent cholangiography (IFC) with concomitant fluorescent angiography is
a recently developed method for non-invasive visualisation of the relevant anatomy during
laparoscopic cholecystectomy. The objective of this study was to assess the time required by
routine-use of IFC and to evaluate success-rate of the procedures.
Methods Thirty-five patients scheduled for laparoscopic cholecystectomy and operated by the
same surgeon were consecutively enrolled. A standardized protocol with IFC including
concomitant angiography was performed during laparoscopic cholecystectomy. Intra-operative
time-registration and exposure of predefined anatomical structures were recorded.
Status | Completed |
Enrollment | 35 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion criteria: - Age > 18 years - Scheduled for acute- or elective laparoscopic cholecystectomy - Informed consent Exclusion criteria: - Known iodine-hypersensitivity - Liver- or renal insufficiency - Known thyrotoxicosis - Pregnancy or lactation |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Denmark | Hvidovre University Hospital | Hvidovre |
Lead Sponsor | Collaborator |
---|---|
Hvidovre University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time expenditure of IFC with concomitant angiography. | Intra-operative fluorescent-imaging-mode-time was registered by a study-nurse during the operations (performed between september and december 2013) | Four months | No |
Secondary | Success-rate of the IFC-procedures. | The operating surgeon completed a structured questionnaire immediately after each operation regarding anatomical identification by IFC (visible cystic duct, -common bile duct, -common hepatic duct, -right and left hepatic ducts, -cystic artery, -aberrant bile ducts, and/or other abnormalities). Successful IFC was defined as exposure of the junction between the cystic duct, common bile duct and common hepatic duct by IFC. Success-full fluorescent angiography was defined as adequate visualisation of the cystic artery within Calot´s triangle by the method. |
Four months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02568852 -
Comparison of Coagulation Factors During Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT01103570 -
Cholecyst- Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy
|
Phase 4 | |
Completed |
NCT02327923 -
Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy
|
Phase 4 | |
Completed |
NCT02317510 -
Combined Spinal Epidural Anesthesia and General Anesthesia for Laparoscopic Cholecystectomy
|
N/A |